It’s the first meeting of the Advisory Committee on Immunization Practices (ACIP) since Kennedy fired all 17 members and appointed eight new panelists, several of whom are vocal vaccine critics.
As part of its scaled-down two-day meeting beginning Wednesday, the committee is set to vote on influenza vaccines that contain thimerosal — an ingredient wrongly linked to autism.
Kennedy has long advocated for banning thimerosal, a preservative that was widely used for decades in a number of biological and drug products, including many vaccines. In his 2014 book, Kennedy said thimerosal was “toxic to brain tissue” and likely caused autism.
Thimerosal, a compound that contains mercury, is used as a preservative to prevent harmful bacteria in multidose vials of vaccines. The compound has been largely phased out as manufacturers have shifted toward single-use vials that contain little or no thimerosal, according to the Centers for Disease Control and Prevention (CDC).
Thimerosal was largely removed from pediatric vaccines by 2001, amid concerns that it could be linked to autism in children. But according to the CDC, “a robust body of peer-reviewed scientific studies conducted in the U.S. and other countries support the safety of thimerosal-containing vaccines.”
The draft agenda for next week’s ACIP meeting revisits issues that scientists and public health experts have long considered to be settled, including the use of the measles mumps, rubella and varicella vaccine in children under 5 years old.
It’s unclear yet what the panel will discuss regarding the shot.
The current CDC childhood vaccine schedule recommends two doses for children, with the first dose at age 12-15 months and the second at age 4-6 years. CDC suggests that the MMR vaccine be given rather than MMRV for the first dose, but both shots have been on the schedule for decades.
Welcome to The Hill’s Health Care newsletter, we’re Nathaniel Weixel, Joseph Choi and Alejandra O’Connell-Domenech — every week we follow the latest moves on how Washington impacts your health.
The Trump administration is shortening ObamaCare’s annual open enrollment period and ending the law’s coverage of immigrants that entered the U.S. illegally as children, according to a final rule announced Friday. The Biden administration made it easier and more affordable to sign up for Affordable Care Act plans, causing enrollment to swell to an all-time high. The Trump administration claims those moves opened a wave …
Patients and doctors say the latest COVID-19 variant spreading in the U.S. in some cases causes a sore throat so painful it has earned the nickname “razor blade throat.” The nimbus variant, which is officially known as NB.1.8.1., is a descendant of the omicron and is being monitored by the World Health Organization. “Your throat is so dry, so cracked, it’s so painful, it’s even hard to drink sometimes,” Muhammad Azam, …
ChatGPT can harm an individual’s critical thinking over time, a study released this month suggests. Researchers at MIT’s Media Lab asked subjects to write several SAT essays and separated subjects into three groups — using OpenAI’s ChatGPT, using Google’s search engine and using nothing, which they called the “brain‑only” group. Each subject’s brain was monitored through electroencephalography (EEG), …
FDA’s vaccine advisory committee meets Wednesday to discuss GlaxoSmithKline’s application for an RSV vaccine in people ages 60+.
In Other News
Branch out with a different read from The Hill:
Agencies they can’t enforce anti-trans bias policies against Catholic groups: Judge
BISMARCK, N.D. (AP) — Two federal agencies cannot punish Catholic employers and health care providers if they refuse for religious reasons to provide gender-affirming care to transgender patients or won’t provide health insurance coverage for such care to their workers, a federal judge ruled Thursday. The ruling from U.S. District …
Senate Parliamentarian Elizabeth MacDonough has ruled that several key pieces of the massive bill to implement President Trump’s agenda run afoul of … Read more
12:30 Report is The Hill’s midday newsletter. Subscribe here or using the box below: Close Thank you for signing up! Subscribe to more newsletters … Read more